Introduction {#section1-1533033819867361}
============

Childhood hematological malignancies include most common cancers in children, of which, leukemia is the one of the most common cancers, accounting for about one-third of all childhood cancers.^[@bibr1-1533033819867361][@bibr2-1533033819867361]-[@bibr3-1533033819867361]^ There are 2 main types of acute leukemia in children, which includes acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). In China, an increased incidence of ALL in children was found year by year since the middle of the last century. Thirty per every 1 000 000 children were diagnosed as ALL each year.^[@bibr4-1533033819867361]^ However, the cause of leukemia is complex, which is generally thought to be the result of environmental and genetic risk factors, as well as genetic-environment interactions, has not been widely determined.^[@bibr5-1533033819867361],[@bibr6-1533033819867361]^ Among the candidate gene polymorphisms, glutathione S-transferase T1 (GSTT1) has been studied as an important genetic variant for childhood acute leukemia. In 1997, Chen *et al* first reported the linkage between GSTT1 polymorphism and incidence of childhood acute leukemia among both black and white children.^[@bibr7-1533033819867361]^ Subsequently, abundant numbers of studies were conducted about GSTT1 null variant and the risk of childhood acute leukemia among various populations. However, the exact relationship of them is still rarely understood. Whether the association differs among people from different race backgrounds was still unclear. Thus, the current meta-analysis was performed aimed to explore an exact association of GSTT1 null genotype and children acute leukemia risk based on included Chinese population.

Materials and Methods {#section2-1533033819867361}
=====================

Search Strategy and Selection Criteria {#section3-1533033819867361}
--------------------------------------

This study was carried out under the guidelines of the PRISMA group.^[@bibr8-1533033819867361]^ Search scopes included articles from PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure, and Chinese Biology Medicine databases published until July 2018. The search keywords were (glutathione S-transferase T1 or GSTT1) and (leukemia or leucocythemia) and (polymorphism or variant) and (child or children). All the language was acceptable. We included all the suitable studies. References of identified studies were also manually screened to search any omitted articles. The inclusion criteria were: (1) studies with case-control design which evaluated the association between GSTT1 null variant and children acute leukemia; (2) studies with a sufficient genotypes data in cases and controls; (3) Chinese populations; (4) we only included the article with most complete data if detected duplicate studies or overlapping populations. Reviews, letter to the editor, case report, and editorial article were included in this search.

Data Extraction {#section4-1533033819867361}
---------------

Based on the inclusion criteria, 2 reviewers independently extracted the data of interest, including first author's name, publication year, geographical areas, sources of control, the types of leukemia, sample size, age, gender, and available data about genotype from participants. All the case-control studies were stratified to hospital-based (HB) and population-based (PB) studies. In this meta-analysis, the quality of individual studies was assessed according to the 9-star Newcastle--Ottawa Scale.^[@bibr9-1533033819867361]^

Statistical Analysis {#section5-1533033819867361}
--------------------

Pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated to assess the relationship of GSTT1-null allele and children acute leukemia risk. The Z test was adopted to explore the significance of the pooled OR. Regarding potential heterogeneity among studies, which assessed by Cochran Q-statistic, we defined significant heterogeneity at the levels *P* \< .10. A random-effects model was used on the overall analysis when significant heterogeneity was observed; otherwise, a fixed-effects model was adopted. Subgroup analyses were conducted by geographical areas (Northern China and Southern China), subtype of acute leukemia (ALL, AML, and acute nonlymphoblastic leukemia \[ANLL\]), age of controls (\<18 years and \>18 years) and sources of control source (HB or PB). Sensitivity analysis was performed by comparing the overall results from 2 different effects model. The funnel plot was used to assess potential publication bias and the Egger test was applied to evaluate the funnel plot asymmetry. Statistical analysis was conducted by Stata version 12.0 (StataCorp LP, College Station, Texas).

Results {#section6-1533033819867361}
=======

Characteristics of Included Articles {#section7-1533033819867361}
------------------------------------

[Figure 1](#fig1-1533033819867361){ref-type="fig"} illustrated the flow chart of inclusion of exclusion process. Sixty-five records were identified about the relationship of GSTT1 polymorphisms and children acute leukemia risk. According to the selection criteria, 7 studies^[@bibr10-1533033819867361][@bibr11-1533033819867361][@bibr12-1533033819867361][@bibr13-1533033819867361][@bibr14-1533033819867361][@bibr15-1533033819867361]-[@bibr16-1533033819867361]^ were suitable and the remaining was removed. The publication year of all included articles ranged from 2003 to 2013. Totally, 439 children acute leukemia cases and 511 controls were used for the current study. Four of the included studies were PB studies. Types of leukemia included ALL, AML, and ANLL. The description of each study is provided in [Table 1](#table1-1533033819867361){ref-type="table"}.

![Flow diagram of the literature search.](10.1177_1533033819867361-fig1){#fig1-1533033819867361}

###### 

Characteristics of Studies Included in the Meta-Analysis.

![](10.1177_1533033819867361-table1)

  References                                  Control Source   Geographical Areas   Leukemia Types   Case Number   Case Age   Case Sex (Male/Female)   Control Number   Control Age   Control Sex (Male/Female)   Cases   Controls   Quality Score        
  ------------------------------------------- ---------------- -------------------- ---------------- ------------- ---------- ------------------------ ---------------- ------------- --------------------------- ------- ---------- --------------- ---- ---
  Zhang^[@bibr10-1533033819867361]^           PB               North China          AML              32            8.91       17/15                    146              \>18          89/57                       19      13         72              74   8
  Feng et al^[@bibr11-1533033819867361]^      PB               North China          AML              49            7.56       26/23                    146              \>18          89/57                       30      19         72              74   8
  Wang et al^[@bibr12-1533033819867361]^      PB               North China          ALL              67            6.9        44/23                    146              \>18          89/57                       41      26         72              74   8
  Lu et al^[@bibr13-1533033819867361]^        HB               South China          AML+ALL +ANLL    61            \<15       36/25                    63               \<15          42/21                       33      28         33              30   7
  Jiang and Tan^[@bibr14-1533033819867361]^   PB               South China          ALL              89            8          49/40                    90               10            48/42                       54      35         44              46   8
  Li et al^[@bibr15-1533033819867361]^        HB               South China          ALL              41            5          25/16                    100              6.6           55/45                       24      17         44              56   8
  Hou and Chen^[@bibr16-1533033819867361]^    HB               South China          ALL              100           5.2        67/33                    112              5.7           65/47                       59      41         55              57   8

Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; ANLL, acute non-lymphoblastic leukemia; PB, population-based; HB, hospital-based; case age/control age, median age or range of age (year).

Meta-Analysis {#section8-1533033819867361}
-------------

[Table 2](#table2-1533033819867361){ref-type="table"} shows the results of GSTT1 polymorphism and childhood acute leukemia risk. We detected no obvious heterogeneity overall. We found a positive relation on childhood acute leukemia risk with the null genotype of GSTT1 polymorphism in all included Chinese populations (ORs: 1.52; 95%CI: 1.19-1.94; [Figure 2](#fig2-1533033819867361){ref-type="fig"}). When conducted the subgroup analysis by geographic areas, similar results were found in Southern China (ORs: 1.48; 95% CI: 1.08-2.02) and Northern China (ORs: 1.59; 95% CI: 1.09-2.33). Furthermore, we only found a significant association in the group of ALL (ORs: 1.61; 95% CI: 1.19-2.17), but not in AML, when we stratified by subtype of acute leukemia. Meanwhile, the hierarchical analysis by age was also done, and we obtained consistent results in the group of "age \>18 years" (ORs: 1.59; 95% CI: 1.09-2.33) and "age \< 18 years" (ORs: 1.48; 95% CI: 1.08-2.02). At last, the positive association was only discovered in PB studies (ORs: 1.60; 95% CI: 1.16-2.20), not in HB studies when we conducted the analysis by sources of control ([Table 2](#table2-1533033819867361){ref-type="table"}).

###### 

Association of the GSTT1 Polymorphism and Children Acute Leukemia Susceptibility.

![](10.1177_1533033819867361-table2)

  Subgroup                        n   Random-Effects Model   Fixed-Effects Model    Heterogeneity   
  ------------------------------- --- ---------------------- ---------------------- --------------- ------
  Total analysis                  7   **1.52 (1.19-1.94)**   **1.52 (1.19-1.94)**   1.27            .973
  Source of control                                                                                 
   Population-based               4   **1.60 (1.16-2.20)**   **1.60 (1.16-2.20)**   0.03            .999
   Hospital-based                 3   1.43 (0.98-2.07)       1.43 (0.98-2.07)       1.04            .596
  Geographic areas                                                                                  
   South China                    4   **1.48 (1.08-2.02)**   **1.48 (1.08-2.02)**   1.15            .764
   North China                    3   **1.59 (1.09-2.33)**   **1.59 (1.09-2.33)**   0.03            .986
  Subtype of acute leukemia                                                                         
   Acute myeloid leukemia         2   1.57 (0.95-2.60)       1.57 (0.95-2.60)       0.02            .882
   Acute lymphoblastic leukemia   4   **1.61 (1.19-2.17)**   **1.61 (1.19-2.17)**   0.16            .984
  Age of controls                                                                                   
   \>18                           3   **1.59 (1.09-2.33)**   **1.59 (1.09-2.33)**   0.03            .986
   \<18                           4   **1.48 (1.08-2.02)**   **1.48 (1.08-2.02)**   1.15            .764

Abbreviations: CI, confidence interval; OR, odds ratio.

The bold-face values means the significant results.

![The forest plots on the association between GSTT1 polymorphism and children acute leukemia susceptibility (fixed-effects model).](10.1177_1533033819867361-fig2){#fig2-1533033819867361}

Sensitivity Analysis and Publication Bias Diagnosis {#section9-1533033819867361}
---------------------------------------------------

Sensitivity analysis which described in the methods was performed, obtaining a consistent result in fixed-effect model and random-effect model. All the significantly pooled ORs were not changed. Therefore, the results in our study were stable ([Table 2](#table2-1533033819867361){ref-type="table"}). The Begg funnel plot and Egger test were used to evaluate the publication bias in this meta-analysis. As shown in [Figure 3](#fig3-1533033819867361){ref-type="fig"}, the shape of the funnel plot did not reveal obvious asymmetry. Similarly, the Egger test indicated that there was no evidence of obvious publication bias in all the included studies (*t* = −0.34, *P* = .750, [Figure 4](#fig4-1533033819867361){ref-type="fig"}).

![Publication bias assessment with Begg funnel plot.](10.1177_1533033819867361-fig3){#fig3-1533033819867361}

![Egger's linear regression.](10.1177_1533033819867361-fig4){#fig4-1533033819867361}

Discussion {#section10-1533033819867361}
==========

Previous articles have obtained an exact association about the GSTT1 null polymorphism and the risk of lung cancer,^[@bibr17-1533033819867361]^ esophageal cancer,^[@bibr18-1533033819867361]^ prostate cancer,^[@bibr19-1533033819867361]^ and so on. But, it still has controversy and uncertainty about the association of GSTT1 null variant on the risk of acute leukemia. Chen *et al*'s study on black and white children suggested that GST genotype plus some other unidentified factors, maybe a risk factor in the development of childhood ALL in American blacks.^[@bibr7-1533033819867361]^ Another meta-analysis concluded that Glutathione S-transferase M1 (GSTM1) null genotype could increase the risk of childhood acute leukemia in Chinese.^[@bibr20-1533033819867361]^ Moreover, several meta-analyses had been conducted about GSTT1G polymorphism on childhood acute leukemia risk.^[@bibr21-1533033819867361][@bibr22-1533033819867361]-[@bibr23-1533033819867361]^ Evidences provided a related susceptibility to ALL in children with GCTT1 null variant among Asian populations.^[@bibr21-1533033819867361][@bibr22-1533033819867361]-[@bibr23-1533033819867361]^ The discovered associations maybe differ among populations who were not in the same race backgrounds. Thus, this study aimed to clarify the potential relation about GSTT1 null genotype and acute leukemia risk in children among Chinese populations.

Our report comprised 7 published articles involving 439 children acute leukemia cases and 511 controls. Findings from the analysis indicated a positive association on the risk of acute leukemia in children with GSTT1 null variant. Subgroup analyses by geographic areas and age of controls gained a similar result in Southern China and Northern China populations, as well as in studies of "age \> 18 years" and "age \< 18 years." Furthermore, it is assumed that the GST genotype frequency may differ between PB studies and HB studies. For this reason, we performed a subgroup analysis by source of controls. As a result, the ORs were not changed, except for HB case-control studies. As far as we know, HB controls who may have other disease cannot be representative of the general population. Therefore, it is more appropriate to use PB controls in case-control studies.

The acute leukemia type may be a confounding factor for the results, we therefore performed the subgroup analysis by acute leukemia type. The results suggested that the GSTT1 null variant may be associated with increased the risk of children ALL (fixed-effect ORs: 1.61; 95% Cis: 1.19-2.17), while no significance was detected among AML children in Chinese population, which was consistent with the previous meta-analyses.^[@bibr21-1533033819867361],[@bibr24-1533033819867361]^ However, meta-analysis published by Moulik *et al*.^[@bibr24-1533033819867361]^ have not searched Chinese databases, and those 2 meta-analyses^[@bibr21-1533033819867361],[@bibr24-1533033819867361]^ had included smaller participants than ours. All the results mentioned above further suggested a strongly association about GSTT1 variant on the risk of children acute leukemia in Chinese population.

Several limitations existed in our study should be attention. Firstly, due to those openly published studies in this meta-analysis, some nonpublished literature met the inclusion criteria may be missed. Secondly, the AML group had small participants when we conducted the subgroup analysis by acute leukemia type, thus, more studies are warranted to further assess the relation between GSTT1 variant and AML risk. Further studies with large sample sizes concerning distinctive clinical types are warranted to elucidate the association. Thirdly, due to the complex etiology of leukemia, the effect of any single gene might have a limited impact on leukemia risk than have been anticipated so far. Although the abovementioned limitations existed, our study had more advantages. Firstly, all the included studies had strictly followed the inclusion and exclusion criteria which we mentioned in the methods, so we can decrease the selection bias in our maximum degree. Secondly, our study is strengthened by exploring the influence of geographic area, age, and clinical type on the risk of children acute leukemia and GSTT1 polymorphism among Chinese populations. Thirdly, we compared the result from fixed-effect model with random-effect model for the sensitivity analysis to prove the reliability and stability of the current article. Therefore, all of these results in our study look more meaningful and significant for the future research.

To sum up, findings from the current study revealed that GSTT1 null polymorphism may be susceptible on childhood acute leukemia among Chinese populations. While some limitations exited in this article, more studies with large sample size are warranted to further confirm these results.
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ALL

:   acute lymphoblastic leukemia

AML

:   acute myeloid leukemia

ANLL

:   acute nonlymphoblastic leukemia

CI

:   confidence interval

GSTT1, HB

:   hospital-based, glutathione S-transferase T1

OR

:   odds ratio

PB

:   population-based.
